Home | Welcome to Contract Pharma   
Last Updated Monday, December 22 2014

Print

Search Results for 'Phase III'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published October 3, 2014
Tabalumab fails to meet efficacy expectations Read More »
By Kristin Brooks
Published January 30, 2014
To provide imaging services for multi-site oncology trial Read More »
By Kristin Brooks
Published January 23, 2014
Reduces LDL-C in statin intolerant patients Read More »
By Kristin Brooks
Published January 23, 2014
Demonstrates statistically significant benefit Read More »
By Gil Roth
Published November 5, 2013
End-of-Phase II meeting with FDA goes well Read More »
Published October 24, 2013
To investigate safety and effectiveness in breast cancer with BRCA1 or BRCA2 gene mutations Read More »
By Gil Roth
Published September 30, 2013
Metastatic melanoma treatment posts positive Phase II results Read More »
Published February 27, 2012
Following Phase II testing, a drug is tested in a large-scale setting (several hundred to several thousand patients) to determine effectiveness, benefits, and the range of possible adverse reactions. Most Phase III studies are randomized and double b… Read More »
By Kim Hovenkamp, Business Develoment Manager
By Dr. Vladimir Novakovskiy, Managing Director

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On